We are live on ! Find out more
BMA

Brooks Moore & Associates Portfolio holdings

AUM $199M
1-Year Est. Return 21.09%
This Fund
S&P 500
This Quarter Est. Return
+14.16%
1 Year Est. Return
+21.09%
3 Year Est. Return
+57.25%
5 Year Est. Return
+77.34%
10 Year Est. Return
AUM
$137M
AUM Growth
+$13.3M
Cap. Flow
-$2.67M
Cap. Flow %
-1.95%
Top 10 Hldgs %
35.4%
Holding
89
New
7
Increased
29
Reduced
29
Closed
1

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$686K
2
SHEL icon
Shell
SHEL
+$470K
3
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$339K
4
EHAB
Enhabit
EHAB
+$334K
5
ETN icon
Eaton
ETN
+$260K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$1.89M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.37M
3
ABBV icon
AbbVie
ABBV
+$1.03M
4
QCOM icon
Qualcomm
QCOM
+$459K
5
BAC icon
Bank of America
BAC
+$444K

Sector Composition

Rank Sector Weight
1 Healthcare 19.15%
2 Consumer Staples 14.37%
3 Technology 12.74%
4 Financials 11.13%
5 Industrials 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$645B
$5.77M 4.22%
32,685
+249
+0.8% +$43K
XOM icon
2
ExxonMobil
XOM
$640B
$5.67M 4.14%
51,441
-3,050
-6% -$327K
MSFT icon
3
Microsoft
MSFT
$2.92T
$5.31M 3.88%
22,147
+290
+1% +$69.6K
CVX icon
4
Chevron
CVX
$381B
$5.1M 3.72%
28,394
-1,314
-4% -$229K
ABT icon
5
Abbott
ABT
$184B
$5M 3.65%
45,538
+300
+0.7% +$31.1K
MRK icon
6
Merck
MRK
$324B
$4.97M 3.63%
44,799
-761
-2% -$77.8K
ABBV icon
7
AbbVie
ABBV
$457B
$4.89M 3.57%
30,233
-6,713
-18% -$1.03M
JPM icon
8
JPMorgan Chase
JPM
$942B
$4.34M 3.17%
32,377
+1,198
+4% +$152K
PEP icon
9
PepsiCo
PEP
$191B
$3.84M 2.8%
21,244
+12
+0.1% +$2.14K
HON icon
10
Honeywell
HON
$77.2B
$3.57M 2.61%
17,673
-27
-0.2% -$5.16K
AAPL icon
11
Apple
AAPL
$4.93T
$3.48M 2.54%
26,790
-547
-2% -$78.2K
KO icon
12
Coca-Cola
KO
$361B
$3.42M 2.5%
53,825
-7
-0% -$423
LMT icon
13
Lockheed Martin
LMT
$135B
$3.42M 2.5%
7,029
-10
-0.1% -$4.65K
HD icon
14
Home Depot
HD
$337B
$3.35M 2.45%
10,614
-40
-0.4% -$12.2K
CSCO icon
15
Cisco
CSCO
$450B
$3.14M 2.29%
65,896
+599
+0.9% +$27.3K
GIS icon
16
General Mills
GIS
$19.5B
$2.94M 2.14%
35,013
-950
-3% -$77.4K
PG icon
17
Procter & Gamble
PG
$346B
$2.93M 2.14%
19,334
+272
+1% +$38.1K
UPS icon
18
United Parcel Service
UPS
$96.2B
$2.76M 2.01%
15,860
+700
+5% +$121K
WMT icon
19
Walmart Inc
WMT
$887B
$2.59M 1.89%
54,750
-1,440
-3% -$68.4K
DD icon
20
DuPont de Nemours
DD
$18.7B
$2.47M 1.81%
28,720
-3,187
-10% -$255K
VOO icon
21
Vanguard S&P 500 ETF
VOO
$967B
$2.45M 1.79%
6,984
+532
+8% +$188K
QCOM icon
22
Qualcomm
QCOM
$178B
$2.4M 1.75%
21,836
-3,924
-15% -$459K
GOOGL icon
23
Alphabet (Google) Class A
GOOGL
$3.99T
$2.38M 1.74%
27,028
+98
+0.4% +$9.31K
TFC icon
24
Truist Financial
TFC
$63.5B
$2.37M 1.73%
55,082
+2,030
+4% +$89K
LOW icon
25
Lowe's Companies
LOW
$119B
$2.22M 1.62%
11,145

Similar funds

Brooks Moore & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Brooks Moore & Associates held 89 positions worth $137M, up 11% from $124M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Brooks Moore & Associates's Q4 2022 filing shows 7 new, 29 increased, 29 reduced and 1 closed positions. Its largest new stake was Organon & Co: 26,815 shares worth $749K. The largest sale was Verizon, an estimated $1.89M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Technology.

  • Brooks Moore & Associates's largest Q4 2022 buy was Organon & Co: 26,815 shares worth $749K.
  • Brooks Moore & Associates added most to Shell in Q4 2022, an estimated $470K increase.
  • Brooks Moore & Associates's biggest Q4 2022 reduction was Verizon, cutting an estimated $1.89M.
  • Brooks Moore & Associates fully exited Invesco Financial Preferred ETF in Q4 2022, selling an estimated $309K.
  • Brooks Moore & Associates's ten largest holdings make up 35% of its $137M portfolio in Q4 2022.
  • Brooks Moore & Associates opened 7 new positions and closed 1 in Q4 2022.
  • Brooks Moore & Associates's portfolio value rose 11% quarter-over-quarter to $137M.

Based on Brooks Moore & Associates's 13F filing for Q4 2022, filed 3 Feb 2023.